Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 9,500 shares, a drop of 61.1% from the February 28th total of 24,400 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average […]
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 5.8 % NASDAQ DFFN opened at $4.86 on Friday. Diffusion Pharmaceuticals has a twelve month low of $4.64 and a twelve month high […]
Research Analysts’ new coverage for Sunday, March 26th: StockNews.com assumed coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU) (TSE:AMM). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Atlas Air Worldwide (NASDAQ:AAWW). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of Advanced Emissions Solutions […]
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) is set to post its quarterly earnings results on Friday, March 24th. Diffusion Pharmaceuticals Trading Down 3.3 % NASDAQ:DFFN traded down $0.19 during midday trading on Thursday, reaching $5.65. The company had a trading volume of 4,032 shares, compared to its average volume of 7,947. The firm has a […]